Krystal Biotech stock trades on Nasdaq, and Citigroup provides analyst ratings and price targets for the company.
2 reports, 1 independent
Updated Jul 29
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Krystal Biotech stock trades on Nasdaq, and Citigroup provides analyst ratings and price targets for the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Krystal Biotech, Inc.
biotechnology company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
-
Citigroup
American investment bank and financial services corporation
Related events
- CleanSpark traded on the Nasdaq stock exchange, and Citigroup provided research reports and ratings.
- BioMarin Pharmaceutical stock received updates on July 18, 2026, including a price target boost from Citigroup, reported by Benzinga.
- Cullinan Therapeutics stock is listed on Nasdaq, as reported by Benzinga.
- Jefferies, Citigroup, and Leerink Partners issued rating updates and price targets for Phathom Pharmaceuticals.
- Amundi increased its stake in Kroger stock and Citigroup issued a price objective on Kroger shares.